Here, we assessed the significance of CD9 expression in primary neuroblastomas using clinical and molecular tumor data, unraveled the upstream activating and repressive control including epigenetic events and analyzed the functional role of CD9 using targeted CD9 re-expression in cell and animal models of neuroblastoma. The gene discussed is CD9; the disease is neuroblastoma.